article · Discover Applied Sciences
The inhibitive effect of expired esofag-d on aluminium-6061 corrosion in 1 M H2SO4 solution was investigated via experimental and theoretical methods, supplemented by optimization using response surface methodology (RSM). Fourier transform infrared (FTIR) spectroscopy and gas chromatography-mass spectrometry (GC–MS) were deployed to characterise the inhibitor. The inhibition efficiency (IE) of esofag-d increased with the rise in esofag’s concentration and decreased as temperature increased. The FTIR analysis results showed the existence of heteroatoms in the drug. GC–MS results indicated that the drug contains diethyl phthalate, pentadecane, tridecane, octadecane, nonadecane, tetradecanoic acid, sulfurous acid, 2-propyl tridecyl ester, n-hexadecanoic acid, dodecanoic acid, among other compounds that contain heteroatoms. The adsorption study performed shows that the Langmuir model gave the finest description of the experimental data. Potentiodynamic polarization results revealed that esofag-d is a mixed-type inhibitor. Nyquist plot from the electrochemical impedance spectroscopy study gave depressed semi-circles and corrosion inhibition efficiency of 95.92%. DFT parameters further confirm the inhibitive ability of the inhibitor. RSM was used to model the combined effect of the variables on the corrosion process. RSM modelling gave an optimum IE of 92.03%, which was further improved by artificial neural network (ANN) modelling. The results obtained show that esofag-d is a good inhibitor for aluminium-6061. Hence, this study has established the viability of expired pharmaceuticals such as expired esofag-d in the corrosion inhibition of Al-6061.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s42452-025-07034-w
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.